Ads
related to: sickle cell crisis pathophysiology- Safety Information
Review Information On Adverse
Reactions & Additional Safety Data.
- Mechanism Of Action
Learn About The LYFGENIA
MOA & How It Works.
- Treatment Pathway
Get An Overview Of The Treatment
Steps With LYFGENIA.
- Support & Resources
Support For Your Patients During
Their Consideration & Treatment.
- Safety Information
Search results
Results From The WOW.Com Content Network
It is possible for a person to have both the gene for hemoglobin S (the form associated with sickle cell anemia) and the gene for hemoglobin C; this state is called hemoglobin SC disease, and is generally more severe than hemoglobin C disease, but milder than sickle cell anemia.
In patients who rely on frequent red cell regeneration e.g. sickle cell disease, a reticulocytopenia can lead to a severe anemia due to the cessation in red cell production (erythropoiesis), referred to as aplastic crisis. [3]
In persons with sickle cell disease, high levels of fetal hemoglobin as found in a newborn or as found abnormally in persons with hereditary persistence of fetal hemoglobin, the HbF causes the sickle cell disease to be less severe. In essence the HbF inhibits polymerization of HbS. A similar mechanism occurs with persons who have sickle cell trait.
There is additionally no strong research on the effectiveness of hip core decompression for people with sickle cell disease. [ 11 ] Progression of the disease could possibly be halted by transplanting nucleated cells from bone marrow into avascular necrosis lesions after core decompression, although much further research is needed to establish ...
Hyperviscosity syndrome is a group of symptoms triggered by an increase in the viscosity of the blood.Symptoms of high blood viscosity include spontaneous bleeding from mucous membranes, visual disturbances due to retinopathy, and neurologic symptoms ranging from headache and vertigo to seizures and coma.
Defects of red blood cell membrane production (as in hereditary spherocytosis and hereditary elliptocytosis). [2] Defects in hemoglobin production (as in thalassemia, sickle-cell disease and congenital dyserythropoietic anemia). [2] Defective red cell metabolism (as in glucose-6-phosphate dehydrogenase deficiency and pyruvate kinase deficiency ...